Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Melanoma risk after ovarian stimulation for in vitro fertilization.

Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE; OMEGA-project group.

Hum Reprod. 2015 May;30(5):1216-28. doi: 10.1093/humrep/dev023. Epub 2015 Mar 4.

PMID:
25743782
2.

Intrauterine insemination or intracervical insemination with cryopreserved donor sperm in the natural cycle: a cohort study.

Kop PA, van Wely M, Mol BW, de Melker AA, Janssens PM, Arends B, Curfs MH, Kortman M, Nap A, Rijnders E, Roovers JP, Ruis H, Simons AH, Repping S, van der Veen F, Mochtar MH.

Hum Reprod. 2015 Mar;30(3):603-7. doi: 10.1093/humrep/dev004. Epub 2015 Jan 29.

PMID:
25637621
3.

Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.

Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.

Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27.

PMID:
24166594
4.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group.

Hum Reprod. 2013 Dec;28(12):3358-69. doi: 10.1093/humrep/det340. Epub 2013 Sep 5.

PMID:
24014607
5.

Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: a randomized controlled trial.

Rijken-Zijlstra TM, Haadsma ML, Hammer C, Burgerhof JG, Pelinck MJ, Simons AH, van Echten-Arends J, Arts JG, Land JA, Groen H, Hoek A.

Reprod Biomed Online. 2013 Sep;27(3):297-304. doi: 10.1016/j.rbmo.2013.05.009. Epub 2013 May 22.

PMID:
23876971
6.

Analysis of biomarker expression in severe endometriosis and determination of possibilities for targeted intraoperative imaging.

van den Berg LL, Crane LM, van Oosten M, van Dam GM, Simons AH, Hofker HS, Bart J.

Int J Gynaecol Obstet. 2013 Apr;121(1):35-40. doi: 10.1016/j.ijgo.2012.10.025. Epub 2013 Jan 16.

PMID:
23332132
7.

Validity of self-reported data on pregnancies for childhood cancer survivors: a comparison with data from a nationwide population-based registry.

Overbeek A, van den Berg MH, Hukkelhoven CW, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJ, Loonen JJ, Versluys AB, Bresters D, Kaspers GJ, Lambalk CB, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER/VEVO Study Group.

Hum Reprod. 2013 Mar;28(3):819-27. doi: 10.1093/humrep/des405. Epub 2012 Nov 21.

PMID:
23175500
8.

Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, André MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Nov 1;30(31):3854-63. doi: 10.1200/JCO.2011.40.8906. Epub 2012 Sep 24.

PMID:
23008303
9.

A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges.

Overbeek A, van den Berg MH, Kremer LC, van den Heuvel-Eibrink MM, Tissing WJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJ, Lambalk CB, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

BMC Cancer. 2012 Aug 23;12:363. doi: 10.1186/1471-2407-12-363.

10.

Factors associated with dizygotic twinning after IVF treatment with double embryo transfer.

Groeneveld E, Lambers MJ, Stakelbeek ME, Mooij TM, van den Belt-Dusebout AW, Heymans MW, Schats R, Hompes PG, Hoek A, Burger CW, van Leeuwen FE, Lambalk CB; OMEGA-project group.

Hum Reprod. 2012 Oct;27(10):2966-70. Epub 2012 Jul 10.

PMID:
22786776
11.

Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Jan 20;30(3):291-9. doi: 10.1200/JCO.2011.37.1989. Epub 2011 Dec 19.

PMID:
22184372
12.

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ, Willemsen WN, Smeenk JM, Simons AH, van der Veen F, Evers JL, van Dop PA, Macklon NS, Burger CW.

Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26.

13.

The European Society of Human Reproduction and Embryology guideline for the diagnosis and treatment of endometriosis: an electronic guideline implementability appraisal.

van Dijk LJ, Nelen WL, D'Hooghe TM, Dunselman GA, Hermens RP, Bergh C, Nygren KG, Simons AH, de Sutter P, Marshall C, Burgers JS, Kremer JA.

Implement Sci. 2011 Jan 19;6:7. doi: 10.1186/1748-5908-6-7.

14.

[IVF in a modified natural cycle].

Bos AM, Pelinck MJ, Dumoulin JC, Arts EG, van Echten-Arends J, Simons AH.

Ned Tijdschr Geneeskd. 2010;154(45):A2519. Review. Dutch.

PMID:
21118595
15.

Fertility preservation after chemotherapy for Hodgkin lymphoma.

van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC.

Hematol Oncol. 2010 Dec;28(4):168-79. doi: 10.1002/hon.939. Review.

PMID:
20232475
16.

Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation.

Haadsma ML, Groen H, Mooij TM, Burger CW, Broekmans FJ, Lambalk CB, Leeuwen FE, Hoek A; OMEGA Project Group.

Reprod Biomed Online. 2010 Feb;20(2):191-200. doi: 10.1016/j.rbmo.2009.11.005. Epub 2009 Nov 26.

PMID:
20113957
17.

A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women.

Haadsma ML, Mooij TM, Groen H, Burger CW, Lambalk CB, Broekmans FJ, van Leeuwen FE, Bouman K, Hoek A; OMEGA Project Group.

Hum Reprod. 2010 Feb;25(2):552-8. doi: 10.1093/humrep/dep404. Epub 2009 Nov 17.

PMID:
19920066
18.

Perinatal outcome in singletons after modified natural cycle IVF and standard IVF with ovarian stimulation.

Pelinck MJ, Keizer MH, Hoek A, Simons AH, Schelling K, Middelburg K, Heineman MJ.

Eur J Obstet Gynecol Reprod Biol. 2010 Jan;148(1):56-61. doi: 10.1016/j.ejogrb.2009.09.015.

PMID:
19850400
19.

Embryo quality and impact of specific embryo characteristics on ongoing implantation in unselected embryos derived from modified natural cycle in vitro fertilization.

Pelinck MJ, Hoek A, Simons AH, Heineman MJ, van Echten-Arends J, Arts EG.

Fertil Steril. 2010 Jul;94(2):527-34. doi: 10.1016/j.fertnstert.2009.03.076. Epub 2009 May 12.

PMID:
19439287
20.

Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation.

Pelinck MJ, Knol HM, Vogel NE, Arts EG, Simons AH, Heineman MJ, Hoek A.

Hum Reprod. 2008 Aug;23(8):1808-14. doi: 10.1093/humrep/den155. Epub 2008 May 14.

PMID:
18480088

Supplemental Content

Loading ...
Support Center